345 related articles for article (PubMed ID: 24643666)
1. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.
Stepanyan G; Badhwar N; Lee RJ; Marcus GM; Lee BK; Tseng ZH; Vedantham V; Olgin J; Scheinman M; Gerstenfeld EP
J Interv Card Electrophysiol; 2014 Jun; 40(1):33-8. PubMed ID: 24643666
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
Aryal MR; Ukaigwe A; Pandit A; Karmacharya P; Pradhan R; Mainali NR; Pathak R; Jalota L; Bhandari Y; Donato A
Am J Cardiol; 2014 Aug; 114(4):577-82. PubMed ID: 24998087
[TBL] [Abstract][Full Text] [Related]
3. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
Europace; 2014 Oct; 16(10):1443-9. PubMed ID: 25115168
[TBL] [Abstract][Full Text] [Related]
4. A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation.
Snipelisky D; Ray JC; Ung R; Duart M; Kauffman C; Kusumoto F
J Interv Card Electrophysiol; 2014 Dec; 41(3):231-6. PubMed ID: 25380703
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the safety of rivaroxaban versus dabigatran therapy in patients with persistent atrial fibrillation].
Gorzelak-Pabiś P; Duraj I; Szlagowska L; Ciastkowska A; Broncel M
Pol Merkur Lekarski; 2014 Nov; 37(221):261-4. PubMed ID: 25546985
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
Providência R; Marijon E; Albenque JP; Combes S; Combes N; Jourda F; Hireche H; Morais J; Boveda S
Europace; 2014 Aug; 16(8):1137-44. PubMed ID: 24550347
[TBL] [Abstract][Full Text] [Related]
7. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
[TBL] [Abstract][Full Text] [Related]
8. A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillation.
Sairaku A; Yoshida Y; Ando M; Hirayama H; Nakano Y; Kihara Y
Clin Drug Investig; 2013 Nov; 33(11):847-53. PubMed ID: 24081373
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
Providência R; Albenque JP; Combes S; Bouzeman A; Casteigt B; Combes N; Narayanan K; Marijon E; Boveda S
Heart; 2014 Feb; 100(4):324-35. PubMed ID: 23878175
[TBL] [Abstract][Full Text] [Related]
13. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
14. The peri-procedural use of dabigatran in patients undergoing left atrial ablation for atrial fibrillation.
Somani R; Mohajer K; Haley C; Simpson CS; Abdollah H; Baranchuk A; Redfearn DP; Michael K
Cardiovasc Ther; 2014 Oct; 32(5):198-201. PubMed ID: 24889271
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Schneeweiss S; Gagne JJ; Patrick AR; Choudhry NK; Avorn J
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):480-6. PubMed ID: 22787066
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
17. Overview of the new oral anticoagulants: opportunities and challenges.
Yeh CH; Hogg K; Weitz JI
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1056-65. PubMed ID: 25792448
[TBL] [Abstract][Full Text] [Related]
18. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
19. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
Ichiki H; Oketani N; Ishida S; Iriki Y; Okui H; Maenosono R; Namino F; Ninomiya Y; Miyata M; Hamasaki S; Tei C
Pacing Clin Electrophysiol; 2013 Nov; 36(11):1328-35. PubMed ID: 23952291
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
